Bio therapeutics as Novel Technique in Drug Delivery

Bio therapeutic drug delivery system uses drug molecules prepared from living organism naturally or in the laboratory. Fusion proteins, antibodies and therapeutic renewal enzymes are the major used bio therapeutic agents. Human insulin is the first bio therapeutic drug developed by recombinant-DNA technology and was agreed by Eli Lily. These drugs have bought boom in the treatment of cancer, autoimmune disease, inflammatory diseases, hemophilia, cardio vascular disease and some genetic disorders. The character of Bio therapeutics as Novel Technique in Drug Delivery is significant scope. Most bio therapeutic drugs are recombinant monoclonal antibodies which are broad produced in mammalian cell lines because of the need for post-translational modifications that should be alike or at least similar to those obtained in humans.

 

    Related Conference of Bio therapeutics as Novel Technique in Drug Delivery

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Bio therapeutics as Novel Technique in Drug Delivery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in